Skip to main content

Animations

MJFF Publications

121 - 130 of 8571 Results
Title
Year
  • Year
  • 2024
  • 2018
  • 2021
  • 2019
  • 2024
  • 2020
  • 2013
  • 2024
  • 2021
  • 2023
  • Summary Details
    OPEN
    Title: P2RX7, an adaptive immune response gene, is associated with Parkinson's disease risk and age at onset
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x241296015
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorder
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27385
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse
    Journal Name: Biomedicines
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biomedicines9050514
    Citation Count: 6
  • Summary Details
    RESTRICTED
    Title: Clinical phenotype in carriers of intermediate alleles in the huntingtin gene
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2019.05.010
    Best OA location URL:
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-024-02706-0
    Citation Count: 39
  • Summary Details
    OPEN
    Title: The role of RHOT1 and RHOT2 genetic variation on Parkinson disease risk and onset
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.07.003
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: 5-HT1 receptor agonists for the treatment of L-DOPA-induced dyskinesia: From animal models to clinical investigation
    Journal Name: Basal Ganglia
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.baga.2012.12.002
    Best OA location URL:
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Naturally occurring hyperactive variants of human parkin
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s42003-024-06656-x
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
    Journal Name: Alzheimer's Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13195-021-00892-7
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Genome-wide case-only analysis of gene-gene interactions with known Parkinson’s disease risk variants reveals link between LRRK2 and SYT10
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00550-9
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.